Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Centessa Pharmaceuticals plc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −2 vs. Q1 2022
- Shares held
- 71.8M
- −2.73M (−3.7%) vs. Q1 2022
- Total value
- $350.3M
- −$318.6M (−47.6%) vs. Q1 2022
- New holders
- 7
- 14 more added
- Sold out
- 9
- 9 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State of Wyoming | 96 | $0 | 0.00% | +23+31.5% | Added |
| Crewe Advisors LLC | 220 | $1.00K | 0.00% | +220 | New |
| Global Retirement Partners, LLC | 350 | $2.00K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 568 | $3.00K | 0.00% | +568 | New |
| Adirondack Trust Co | 925 | $5.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,225 | $6.00K | 0.00% | +314+34.5% | Added |
| Tower Research Capital LLC (TRC) | 1,477 | $7.00K | 0.00% | +232+18.6% | Added |
| Advisor Group Holdings, Inc. | 1,950 | $8.00K | 0.00% | +935+92.1% | Added |
| Bank of America Corp | 6,046 | $29.0K | 0.00% | −38,131−86.3% | Reduced |
| FMR LLC | 10,300 | $50.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 16,543 | $81.0K | 0.00% | +16,543 | New |
| Jane Street Group, LLC | 39,335 | $192.0K | 0.00% | +39,335 | New |
| Morgan Stanley | 40,264 | $196.0K | 0.00% | +18,652+86.3% | Added |
| Alps Advisors Inc | 55,785 | $272.0K | 0.00% | +55,785 | New |
| Oasis Management Co Ltd. | 57,700 | $281.0K | 0.05% | +57,700 | New |
| Manufacturers Life Insurance Company, The | 57,421 | $286.5K | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 82,055 | $400.0K | 0.00% | +48,803+146.8% | Added |
| Ensign Peak Advisors, Inc | 123,071 | $599.0K | 0.00% | −193,530−61.1% | Reduced |
| Point72 Asset Management, L.P. | 133,600 | $651.0K | 0.00% | −773,400−85.3% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 57,342 | $703.0K | 0.00% | +57,342 | New |
| JPMorgan Chase & Co | 178,414 | $869.0K | 0.00% | +173,698+3,683.2% | Added |
| Citadel Advisors LLC | 290,583 | $1.42M | 0.00% | −13,843−4.5% | Reduced |
| EcoR1 Capital, LLC | 292,320 | $1.42M | 0.05% | −162,225−35.7% | Reduced |
| BlackRock Inc. | 301,915 | $1.47M | 0.00% | +25,397+9.2% | Added |
| Logos Global Management LP | 399,801 | $1.95M | 0.36% | −54,744−12.0% | Reduced |
| American Century Companies Inc | 517,577 | $2.52M | 0.00% | +342+0.1% | Added |
| Kynam Capital Management, LP | 757,848 | $3.69M | 0.95% | +88,748+13.3% | Added |
| Franklin Resources Inc | 832,932 | $4.06M | 0.00% | +216,029+35.0% | Added |
| Baker Bros. Advisors LP | 1,127,273 | $5.49M | 0.03% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,251,137 | $6.09M | 0.39% | 00.0% | Unchanged |
| Woodline Partners LP | 1,314,652 | $6.40M | 0.10% | +432,019+48.9% | Added |
| Samsara BioCapital, LLC | 1,693,736 | $8.25M | 2.21% | −190,360−10.1% | Reduced |
| Price T Rowe Associates Inc | 2,461,130 | $12.0M | 0.00% | −67,453−2.7% | Reduced |
| Cormorant Asset Management, LP | 2,927,273 | $14.3M | 1.11% | +437,379+17.6% | Added |
| OUP Management Co., LLC | 2,937,615 | $14.3M | 19.69% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 3,428,520 | $16.7M | 0.01% | −2,189,299−39.0% | Reduced |
| Vida Ventures Advisors, LLC | 3,931,818 | $19.1M | 16.18% | 00.0% | Unchanged |
| BVF Inc | 6,894,345 | $33.6M | 1.62% | +5,138,800+292.7% | Added |
| General Atlantic LLC | 9,681,818 | $47.1M | 0.62% | 00.0% | Unchanged |
| Index Venture Life Associates VI Ltd | 9,961,789 | $48.5M | 100.00% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $97.2M | 40.37% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −3,577,094−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −1,053,142−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −727,273−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −411,361−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −65,282−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −13,969−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −11,400−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Golden State Equity Partners | – | – | – | – | Not filed |